Error: Could not add to watchlist. X
+ Watchlist

Innexus Biotechnology Inc

IXSBF:US
OTC US
0.00
USD
0.00
0.00%
As of 8:10 PM EDT 7/13/2017
Volume
32,492
Previous Close
0.00
52Wk Range
0.00 - 0.00
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
32,492
Previous Close
0.00
52Wk Range
0.00 - 0.00
YTD Return
900.00%
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.06%
% Price Change
+0.10%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
InNexus Biotechnology Inc. is developing a new generation of monoclonal antibodies termed SuperAntibodies (SAT). The Company is exploiting SAT to generate second generation diagnostic and therapeutic antibodies. InNexus is focused on marketing the SAT to the pharmaceutical community for the purpose of entering into licensing agreements.
Address
1400 - 400 Burrard Street
Vancouver, BC V6C 3G2
Canada
Phone
1-604-689-1749